SAGE – Sage Therapeutics & LGND – Ligand Pharmaceuticals PDUFA for Brexanolone – SAGE-547

When:
March 19, 2019 all-day
2019-03-19T00:00:00-04:00
2019-03-20T00:00:00-04:00

$SAGE – Sage Therapeutics & $LGND – Ligand Pharmaceuticals PDUFA for Brexanolone – SAGE-547
the PDUFA date was extended three months to March 19, 2019.
Advisory Committee meeting November 2, 2018 voted 17-1 recommending approval.

Sage Therapeutics Receives Notification of PDUFA Extension for ZULRESSO™ (brexanolone) Injection

Leave a Reply